Should India allow Direct-to-consumer pharmaceutical advertising (DTCPA)?

Unethical pharmaceutical advertising practices have for long been a bone of contention for the Government as well as patient right groups. Time and again, the pharmaceutical industry has been accused of adopting questionable practices in relation to the marketing of their products. The main focus of attention in this respect has been suspect interactions between […]

Direct-to-consumer pharmaceutical advertising (DTCPA)?

Direct-to-consumer pharmaceutical advertising (DTCPA) has grown rapidly during the past several decades and is now the most prominent type of health communication that the public encounters. DTCA for pharmaceuticals was legalized in 1997. Despite its relatively short 22-year existence, it has heavily impacted the advertising landscape for U.S. healthcare and stands in stark contrast to […]